5.7M cash in bank, that'll get them to March 2016 on their...

5.7M cash in bank, that'll get them to March 2016 on their current burn rate, assuming they won't plan to sink any more into R&D (if ANSTO is successfull this will be a problem). But more importantly, there's been no talk of starting up revenues to sustain the company. The only way for them to progress will be equity dilutive capital raisings until such a time they reach product proof, market their product and source some actual cash flow into the company. Sure there's opportunity for this assuming the product is successful in its current development of phase, however how diluted will current shareholders capital be before then?

It could be possible for the company to generate some positive newsflow to get the current share price above the partly paids, but this is purely speculative as we don't know the outcome of the ANSTO testing and the eventual commerciality of the product.

Green, are you confident the company will be able to fund all current and future development as it currently stands? If so why and how?